Viewing StudyNCT00093379



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00093379
Status: COMPLETED
Last Update Posted: 2023-04-18
First Post: 2004-10-06

Brief Title: Capecitabine Oxaliplatin and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Anal Cancer
Keywords:
Name View
XRT View
stage II anal cancer View
stage IIIA anal cancer View
stage IIIB anal cancer View
squamous cell carcinoma of the anus View
Capecitabine View
Xeloda View
Oxaliplatin View
Eloxatin View
Radiotherapy View